What Is Oxidative Stress? Causes, Biomarkers, and the NAD+ Connection

Key Takeaways

• Oxidative stress is a normal part of metabolism that becomes harmful when reactive oxygen species (ROS) chronically overwhelm the body’s antioxidant and repair systems.
• Mitochondria, inflammation, DNA repair, and NAD+ metabolism are tightly interconnected in shaping how cells respond to oxidative stress and how this response changes with aging.
• Oxidative stress can be assessed using a panel of biomarkers, which allow researchers or clinicians to objectively evaluate interventions in humans.
• Human studies of NAD+ precursors (NR, NMN, niacin, NAM) have shown measurable shifts in some oxidative stress markers in certain populations, but results are mixed and context‑dependent.
• Maintaining healthy redox balance relies most strongly on foundational lifestyle practices—physical activity, sleep, smoking cessation, and nutrient‑dense diets—with NAD+ precursors representing a promising but still evolving complement to these core strategies.

Oxidative stress is a widely used term in wellness circles—but it’s not just a buzzword, it’s a well-established concept in cellular biology. Often used as a shorthand for free radical damage, oxidative stress actually has a more precise meaning: it refers to an imbalance between reactive molecules produced during normal metabolism and the antioxidant and repair systems that keep them in check.¹ This imbalance is becoming increasingly recognized as a central theme in longevity and healthspan research because it sits at the intersection of mitochondrial function, inflammation, DNA repair, and the biology of aging. 

Everyday life depends on metabolic processes that convert nutrients into usable energy, particularly inside the mitochondria. But those same processes also generate reactive oxygen species (ROS) and related byproducts that can modify lipids, proteins, and DNA.² Under healthy conditions, the body manages these reactive molecules with antioxidant defenses and repair pathways³—but when this balance is chronically disrupted, elevated oxidative stress can drive cellular damage, loss of resilience, and increased risk for tissue dysfunction and age-related disease.⁴

Within this context, nicotinamide adenine dinucleotide (NAD+) has emerged as one of the key molecules under investigation for its role in maintaining cellular resilience to oxidative stress. As an essential cofactor for energy metabolism, NAD+ supports mitochondrial function and fuels enzymes involved in DNA repair and stress responses, including PARPs and sirtuins,⁵ and its decline with age has been linked to reduced stress resilience.⁶

Therefore, researchers are actively studying whether restoring NAD+ with precursors such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) can help support these systems that respond to oxidative and inflammatory challenges. In this article, we'll take a closer look at what oxidative stress is, how it is measured in humans, how it changes with age, and what current research reveals about the relationship between NAD+ precursors and oxidative stress. 

What Is Oxidative Stress? A Foundational Overview

Oxidative stress begins with molecules called reactive oxygen species (ROS), which are highly reactive forms of oxygen that arise naturally as byproducts of metabolism, primarily in the mitochondria.⁷ They are also generated during immune responses⁸ and by environmental exposures.⁹ At low levels, ROS are not inherently harmful—they actually play important roles in cellular signaling,⁴ helping cells to adapt to changing conditions and respond to pathogens. 

However, to function well over time, cells need to maintain an oxidative balance—an equilibrium between the production of ROS and the capacity of antioxidant and repair systems to neutralize or repair their effects. Oxidative stress is essentially a disruption of this balance, where ROS and other oxidants accumulate faster than the body’s defense systems can manage them.¹⁰ When this happens chronically, excess ROS can chemically modify and damage key cellular components, including membrane lipids, structural and enzymatic proteins, nuclear and mitochondrial DNA, and the mitochondria themselves.¹⁰

Many everyday factors can tip the scales toward oxidative stress. Diets low in nutrient density¹¹ or high in pro-inflammatory foods,¹² excess alcohol consumption,¹³ smoking¹⁴ and vaping,¹⁵ exposure to air pollution,¹⁶ and UV radiation¹⁷ can increase ROS production, while chronic inflammation and metabolic dysfunction (such as insulin resistance¹⁸ or obesity¹⁹) can further amplify oxidative processes and strain antioxidant defenses. Over time, this sustained excess of ROS can contribute to cellular aging and tissue changes associated with reduced resilience and higher risk of chronic disease.²⁰

How Is Oxidative Stress Measured?

Researchers often talk about oxidative stress—but how is it actually measured in the body? Rather than relying on a single test, scientists assess oxidative stress using a panel of biomarkers that reflect different aspects of oxidative damage or antioxidant defense.²¹ Because there is no universally accepted gold-standard biomarker, oxidative stress is evaluated by considering the overall pattern of biomarker results alongside the study population and experimental design, rather than any single measurement alone.

Most commonly, oxidative stress biomarkers fall into four major categories: damage to fats, damage to DNA, damage to proteins, and overall antioxidant capacity.²¹ These same classes of biomarkers are used in both research and clinical settings, although they are typically interpreted as part of a broader clinical or research context rather than as a standalone diagnostic test. For example, 8‑hydroxy‑2′‑deoxyguanosine (8‑OHdG) is a measure of oxidative damage to DNA,²² while malondialdehyde (MDA) and F2‑isoprostanes indicate damage to fats in cell membranes.²³'²⁴ Other tests, such as total antioxidant capacity (TAC) assays, don’t measure damage directly.²⁵ Instead, they capture the combined activity of multiple antioxidant molecules and enzymes rather than the damage itself. 

Each of these biomarkers has strengths and limitations. Some are better at detecting certain types of damage than others. For example, F2-isoprostanes are among the most reliable markers of oxidative damage to fats because they are considered relatively stable.²⁴ However, they can vary by tissue type and are influenced by diet, lifestyle, and underlying health conditions.²⁶ Markers of DNA and protein damage can show whether oxidative stress has affected those molecules, but they can fluctuate over time and are often affected by sample handling and analytical methods.²⁷ Lastly, measures of TAC can help provide a broader measure of antioxidant defenses, but they cannot pinpoint where damage may be occurring.²⁸

Overall, these biomarkers form the framework that researchers can use to interpret human studies on oxidative stress. By measuring patterns across several markers, rather than relying on a single biomarker, scientists can build a more nuanced picture of whether oxidative stress is present, which tissues might be affected, and how interventions (like NAD+ and its precursors) can influence overall oxidative balance.

Oxidative Stress and Aging: A Two-Way Relationship

Oxidative stress and aging are deeply intertwined—and the relationship runs in both directions, meaning oxidative stress influences aging and vice versa.²⁹ Over time, age-related changes in cellular function can increase oxidative stress,³⁰ while accumulated oxidative damage can further accelerate the aging process itself. Historically, this idea was introduced as the Free Radical Theory of Aging, which proposed that cumulative damage from reactive molecules like ROS is a major driver of aging.³¹ Today, that view has evolved,³² and oxidative stress is now understood as one important contributor within a larger network of aging processes.

As we age, mitochondria tend to become less efficient and more prone to dysfunction.³³ These dysfunctional mitochondria can produce higher levels of ROS, especially when electron transport becomes “leaky” during oxidative phosphorylation. The resulting oxidative stress can damage mitochondrial DNA, proteins, and membranes, further impairing mitochondrial function and creating a self-reinforcing cycle: aging promotes mitochondrial dysfunction, dysfunctional mitochondria generate more ROS, and the accumulated oxidative damage feeds back into cellular aging.³³ This buildup of oxidative damage contributes to several hallmarks of aging, including genomic instability, loss of proteostasis, impaired nutrient sensing, cellular senescence, and altered intercellular communication.

Oxidative stress also intersects with chronic low-grade inflammation,³⁴ often referred to as “inflammaging.” Reactive species like ROS can activate inflammatory signaling pathways and promote the release of cytokines, while persistent inflammation can then, in turn, increase ROS production through immune cell activity and metabolic changes.³⁵ This bidirectional relationship can gradually impair tissue integrity and resilience, especially in metabolically active or immune-responsive organs.³⁶

Given this complexity, antioxidant supplementation trials have often produced mixed or even negative results.³⁷'³⁸ Using high-dose antioxidant pills to scavenge ROS directly does not fully address upstream processes like mitochondrial dysfunction, impaired repair pathways, or chronic inflammation. As a result, attention has increasingly shifted toward strategies that support the cellular systems that regulate oxidative stress upstream—mitochondrial health, DNA repair mechanisms, and key metabolic cofactors like NAD+ and its precursors—rather than relying on blanket antioxidant approaches.

Where NAD+ Comes In: Redox Balance, DNA Repair, and Cellular Resilience

NAD+ is a central player in how cells make energy, respond to stress, and maintain redox balance, which is why researchers are studying its role in oxidative stress and aging. As an essential coenzyme, NAD+ sits at the crossroads of mitochondrial function, DNA repair, and stress-response signaling, making it a key molecule for cellular resilience.³⁹ NAD+ is best known as an electron carrier in energy metabolism, cycling between NAD+ and NADH as it shuttles electrons to the mitochondrial electron transport chain.⁴⁰ The balance between NAD+ and NADH (the NAD+/NADH ratio) is important for redox homeostasis, influencing how efficiently mitochondria produce ATP and how many stray electrons escape to form ROS.⁴¹ When NAD+ is sufficient and this ratio is favorable, mitochondrial respiration tends to run more cleanly, supporting energy production while limiting excess ROS.

NAD+ also fuels enzymes that help coordinate stress responses and antioxidant defenses, such as sirtuins like mitochondrial SIRT3, which help mitochondria manage reactive species.⁴² It is also consumed by DNA repair enzymes called PARPs, which are activated by oxidative DNA damage.⁴³ When PARPs are chronically activated, they can deplete NAD+, potentially leaving less available for mitochondrial function and other NAD-dependent defenses. Research in human skin tissue has found that aging is linked with increased oxidative DNA damage and PARP activity, along with lower NAD+ and reduced SIRT1 activity, suggesting that age‑related oxidative stress may contribute to declining NAD+‑dependent resilience in tissue.⁴⁴ 

Because NAD+ is embedded in these energy, repair, and stress‑response pathways, recent human studies of NAD+ precursors like NR and NMN often include oxidative stress biomarkers to see whether supporting NAD+ levels can translate into changes in oxidative stress.

What Human Studies Show: NAD+ Precursors and Oxidative Stress Markers

Now that NAD+’s role in redox balance, mitochondrial function, and DNA repair has been outlined, the key question is what happens when NAD+ precursors like NR, NMN, niacin, or nicotinamide (NAM) are tested against oxidative stress biomarkers in clinical studies. Human studies are beginning to examine whether supporting NAD+ with precursors can meaningfully influence oxidative stress biomarkers, but the evidence so far is still emerging and mixed. Across different precursors, populations, and biomarkers, some studies report promising outcomes,⁴⁵ while others show little or no effect on oxidative stress.⁴⁶

Researchers use the biomarkers mentioned earlier—such as F2‑isoprostanes, malondialdehyde (MDA), or 8‑OHdG—as tools to evaluate whether an intervention shifts oxidative damage or antioxidant capacity. A recent pilot trial in patients with chronic kidney disease found that six weeks of NR or coenzyme Q10 (CoQ10) supplementation reduced plasma five‑series F2‑isoprostanes, well‑established markers of oxidative damage to fats.⁴⁵ Both NR and CoQ10 lowered this biomarker compared with placebo, while NR also improved measures of cellular bioenergetics, suggesting a potential dual effect on oxidative stress and mitochondrial function, 

Another small study found that a single NR dose decreased F2-isoprostanes by about 18% in both young and old men, with a non-significant trend toward increased glutathione in the older men.⁴⁷ These findings support the idea that NR can modulate oxidative damage to fats in humans, but the clinical relevance of these changes still needs to be verified in larger and longer trials. 

Evidence from other NAD+ precursors is more variable. Extended-release niacin has been shown to improve certain endothelial-protective functions of HDL in people with type 2 diabetes, including reducing signs of oxidative stress affecting blood vessel cells.⁴⁸ In contrast, a randomized trial of NMN in healthy middle-aged adults found that while NMN effectively elevated NAD+ metabolism, it did not significantly change the DNA oxidation biomarker 8-OHdG compared to placebo, highlighting that increased NAD+ does not automatically translate into reductions in oxidative stress markers.⁴⁶ Similarly, nicotinamide supplementation in individuals with diabetes and non-alcoholic fatty liver disease (NAFLD) did not significantly alter MDA levels compared to placebo, despite other metabolic benefits being reported.⁴⁹

Taken together, these studies suggest a nuanced picture: NR shows the most consistent signal so far for reducing certain lipid peroxidation markers like F2-isoprostanes, especially in populations with elevated cardiovascular risk, while NMN and NAM have not consistently altered oxidative stress biomarkers. Niacin, however, was shown to improve aspects of vascular oxidative stress and HDL function in specific contexts, but its overall antioxidant impact remains mixed.

It’s important to note that the goal of NAD-focused strategies is not to eliminate ROS, but rather to support healthier redox balance and cellular resilience, including helping mitochondria, DNA repair systems, and stress response pathways handle reactive species more effectively over time. As more and larger human studies emerge, oxidative stress biomarkers will continue to serve as a lens for understanding where NAD+ precursors could meaningfully shift the biology of oxidative stress—and where their effects may be more modest, context-dependent, or best combined with other therapeutic approaches.

How to Support Antioxidant Defenses and Mitigate Oxidative Stress

Supporting healthy oxidative balance starts with reducing avoidable sources of excess ROS while strengthening the body’s own antioxidant and repair systems.⁵⁰ The goal is not to eliminate ROS entirely, but to maintain a healthy redox balance, since low to moderate levels of ROS are essential for normal signaling, adaptation, and immune function.

Because oxidative stress often reflects deeper issues, addressing upstream drivers—like poor metabolic health, sleep disruption, and chronic low-grade inflammation—tends to be more impactful than relying on antioxidant supplements. Lifestyle remains the foundation: regular aerobic exercise can induce a hormetic response, which is when small, transient increases in ROS prompt cells to upregulate their endogenous antioxidant and repair defenses.⁵¹ Consistent and sufficient sleep, caloric moderation, and smoking cessation all also play important roles in lowering chronic oxidative burden and improving metabolic and inflammatory profiles.⁵⁰

Dietary antioxidants also matter, as many plant foods provide a broad spectrum of antioxidants and polyphenols—along with vitamins C and E and carotenoids—that support endogenous defenses and integrate into cellular membranes and plasma antioxidant networks.⁵² In general, getting these compounds through whole foods appears to be more beneficial and physiologically balanced than relying on isolated, high-dose supplements. 

Within this broader context, NAD+ precursors like NR, NMN, niacin, and NAM can be viewed as one nutritional strategy among several to support cellular systems that influence oxidative stress. Early human data suggests that they may beneficially shift oxidative stress markers in certain settings, but the evidence remains mixed and not yet definitive. Ultimately, healthy redox balance is most effectively supported through multiple complementary approaches, including foundational lifestyle practices, nutrient-dense dietary patterns, management of metabolic and inflammatory stressors, and targeted nutritional interventions when appropriate.

Oxidative Stress and NAD+: What We Know and What’s Still Emerging

Oxidative stress is a normal part of biology, arising whenever cells produce energy, but it becomes harmful when ROS production is chronically elevated or poorly controlled over time. In that dysregulated state, reactive species can damage fats, proteins, and DNA, linking oxidative stress to mitochondrial dysfunction, chronic low-grade inflammation, impaired DNA repair, and age-related declines in cellular resilience—with NAD+ sitting at the intersection of many of these pathways. 

Because oxidative stress can be measured through validated biomarkers, researchers are able to objectively assess how different interventions influence oxidative damage or antioxidant defense in humans. Within this framework, human studies of NAD+ precursors like NR, NMN, NAM, and niacin have reported measurable changes in some oxidative stress markers in specific populations, but findings remain mixed and must be interpreted within the broader context of study design and population differences. 

Overall, the current evidence supports a multifaceted approach to healthy oxidative balance, including regular physical activity, adequate sleep, and nutrient-dense dietary patterns. NAD+ precursors represent promising—but still evolving—areas of mechanistic and clinical research that may complement these core behaviors rather than replace them. 

References

1. Preiser, J. (2012). Oxidative Stress. Journal of Parenteral and Enteral Nutrition, 36(2), 147–154. https://doi.org/10.1177/0148607111434963
2. Murphy, M. P. (2009). How mitochondria produce reactive oxygen species. Biochemical Journal, 417(Pt 1), 1–13. https://doi.org/10.1042/bj20081386
3. Birben, E., Sahiner, U. M., Sackesen, C., Erzurum, S., & Kalayci, O. (2012). Oxidative Stress and Antioxidant Defense. World Allergy Organization Journal, 5(1), 9–19. https://doi.org/10.1097/wox.0b013e3182439613
4. Pizzino, G., Irrera, N., Cucinotta, M., Pallio, G., Mannino, F., Arcoraci, V., Squadrito, F., Altavilla, D., & Bitto, A. (2017). Oxidative Stress: Harms and Benefits for Human Health. Oxidative Medicine and Cellular Longevity, 2017(1), 8416763. https://doi.org/10.1155/2017/8416763
5. Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021). NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology, 22(2), 119–141. https://doi.org/10.1038/s41580-020-00313-x
6. Fang, E. F., Lautrup, S., Hou, Y., Demarest, T. G., Croteau, D. L., Mattson, M. P., & Bohr, V. A. (2017). NAD+ in Aging: Molecular Mechanisms and Translational Implications. Trends in Molecular Medicine, 23(10), 899–916. https://doi.org/10.1016/j.molmed.2017.08.001
7. Schieber, M., & Chandel, N. S. (2014). ROS Function in Redox Signaling and Oxidative Stress. Current Biology, 24(10), R453–R462. https://doi.org/10.1016/j.cub.2014.03.034
8. Yang, Y., Bazhin, A. V., Werner, J., & Karakhanova, S. (2013). Reactive Oxygen Species in the Immune System. International Reviews of Immunology, 32(3), 249–270. https://doi.org/10.3109/08830185.2012.755176
9. Tanabe, S., O’Brien, J., Tollefsen, K. E., Kim, Y., Chauhan, V., Yauk, C., Huliganga, E., Rudel, R. A., Kay, J. E., Helm, J. S., Beaton, D., Filipovska, J., Sovadinova, I., Garcia-Reyero, N., Mally, A., Poulsen, S. S., Delrue, N., Fritsche, E., Luettich, K., … FitzGerald, R. (2022). Reactive Oxygen Species in the Adverse Outcome Pathway Framework: Toward Creation of Harmonized Consensus Key Events. Frontiers in Toxicology, 4, 887135. https://doi.org/10.3389/ftox.2022.887135
10. Napolitano, G., Fasciolo, G., & Venditti, P. (2021). Mitochondrial Management of Reactive Oxygen Species. Antioxidants, 10(11), 1824. https://doi.org/10.3390/antiox10111824
11. Sun, H., Liang, C., Zuo, B., & Wang, M. (2025). Diet, oxidative stress, and the mediating role of obesity in postmenopausal women. BMC Women’s Health, 25(1), 458. https://doi.org/10.1186/s12905-025-04026-1
12. Prasad, K., & Dhar, I. (2014). Oxidative Stress as a Mechanism of Added Sugar-Induced Cardiovascular Disease. International Journal of Angiology, 23(04), 217–226. https://doi.org/10.1055/s-0034-1387169
13. Tsermpini, E. E., Ilješ, A. P., & Dolžan, V. (2022). Alcohol-Induced Oxidative Stress and the Role of Antioxidants in Alcohol Use Disorder: A Systematic Review. Antioxidants, 11(7), 1374. https://doi.org/10.3390/antiox11071374
14. Ahmadkhaniha, R., Yousefian, F., & Rastkari, N. (2021). Impact of smoking on oxidant/antioxidant status and oxidative stress index levels in serum of the university students. Journal of Environmental Health Science and Engineering, 19(1), 1043–1046. https://doi.org/10.1007/s40201-021-00669-y
15. Kelesidis, T., Tran, E., Nguyen, R., Zhang, Y., Sosa, G., & Middlekauff, H. R. (2021). Association of 1 Vaping Session With Cellular Oxidative Stress in Otherwise Healthy Young People With No History of Smoking or Vaping. JAMA Pediatrics, 175(11), 1174–1176. https://doi.org/10.1001/jamapediatrics.2021.2351
16. Cosselman, K. E., Allen, J., Jansen, K. L., Stapleton, P., Trenga, C. A., Larson, T. V., & Kaufman, J. D. (2020). Acute exposure to traffic-related air pollution alters antioxidant status in healthy adults. Environmental Research, 191, 110027. https://doi.org/10.1016/j.envres.2020.110027
17. Jager, T. L. de, Cockrell, A. E., & Plessis, S. S. D. (2017). Ultraviolet Light in Human Health, Diseases and Environment. Advances in Experimental Medicine and Biology, 996, 15–23. https://doi.org/10.1007/978-3-319-56017-5_2
18. Hurrle, S., & Hsu, W. H. (2017). The etiology of oxidative stress in insulin resistance. Biomedical Journal, 40(5), 257–262. https://doi.org/10.1016/j.bj.2017.06.007
19. Manna, P., & Jain, S. K. (2015). Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies. Metabolic Syndrome and Related Disorders, 13(10), 423–444. https://doi.org/10.1089/met.2015.0095
20. Reddy, V. P. (2023). Oxidative Stress in Health and Disease. Biomedicines, 11(11), 2925. https://doi.org/10.3390/biomedicines11112925
21. Azzi, A. (2022). Oxidative Stress: What Is It? Can It Be Measured? Where Is It Located? Can It Be Good or Bad? Can It Be Prevented? Can It Be Cured? Antioxidants, 11(8), 1431. https://doi.org/10.3390/antiox11081431
22. VALAVANIDIS, A., VLACHOGIANNI, T., & FIOTAKIS, C. (2009). 8-hydroxy-2′ -deoxyguanosine (8-OHdG): A Critical Biomarker of Oxidative Stress and Carcinogenesis. Journal of Environmental Science and Health, Part C, 27(2), 120–139. https://doi.org/10.1080/10590500902885684
23. Cordiano, R., Gioacchino, M. D., Mangifesta, R., Panzera, C., Gangemi, S., & Minciullo, P. L. (2023). Malondialdehyde as a Potential Oxidative Stress Marker for Allergy-Oriented Diseases: An Update. Molecules, 28(16), 5979. https://doi.org/10.3390/molecules28165979
24. Ma, E., Ingram, K. H., Milne, G. L., & Garvey, W. T. (2017). F2-Isoprostanes Reflect Oxidative Stress Correlated With Lean Mass and Bone Density but Not Insulin Resistance. Journal of the Endocrine Society, 1(5), 436–448. https://doi.org/10.1210/js.2017-00006
25. Silvestrini, A., Meucci, E., Ricerca, B. M., & Mancini, A. (2023). Total Antioxidant Capacity: Biochemical Aspects and Clinical Significance. International Journal of Molecular Sciences, 24(13), 10978. https://doi.org/10.3390/ijms241310978
26. Milne, G. L., Dai, Q., & Roberts, L. J. (2015). The isoprostanes—25 years later. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1851(4), 433–445. https://doi.org/10.1016/j.bbalip.2014.10.007
27. Graille, M., Wild, P., Sauvain, J.-J., Hemmendinger, M., Canu, I. G., & Hopf, N. B. (2020). Urinary 8-OHdG as a Biomarker for Oxidative Stress: A Systematic Literature Review and Meta-Analysis. International Journal of Molecular Sciences, 21(11), 3743. https://doi.org/10.3390/ijms21113743
28. Silvestrini, A., & Mancini, A. (2024). The Double-Edged Sword of Total Antioxidant Capacity: Clinical Significance and Personal Experience. Antioxidants, 13(8), 933. https://doi.org/10.3390/antiox13080933
29. Maldonado, E., Morales-Pison, S., Urbina, F., & Solari, A. (2023). Aging Hallmarks and the Role of Oxidative Stress. Antioxidants, 12(3), 651. https://doi.org/10.3390/antiox12030651
30. Liguori, I., Russo, G., Curcio, F., Bulli, G., Aran, L., Della-Morte, D., Gargiulo, G., Testa, G., Cacciatore, F., Bonaduce, D., & Abete, P. (2018). Oxidative stress, aging, and diseases. Clinical Interventions in Aging, 13(0), 757–772. https://doi.org/10.2147/cia.s158513
31. Wickens, A. P. (2001). Ageing and the free radical theory. Respiration Physiology, 128(3), 379–391. https://doi.org/10.1016/s0034-5687(01)00313-9
32. Gladyshev, V. N. (2013). The Free Radical Theory of Aging Is Dead. Long Live the Damage Theory! Antioxidants & Redox Signaling, 20(4), 727–731. https://doi.org/10.1089/ars.2013.5228
33. Chistiakov, D. A., Sobenin, I. A., Revin, V. V., Orekhov, A. N., & Bobryshev, Y. V. (2014). Mitochondrial Aging and Age‐Related Dysfunction of Mitochondria. BioMed Research International, 2014(1), 238463. https://doi.org/10.1155/2014/238463
34. Biswas, S. K. (2016). Does the Interdependence between Oxidative Stress and Inflammation Explain the Antioxidant Paradox? Oxidative Medicine and Cellular Longevity, 2016(1), 5698931. https://doi.org/10.1155/2016/5698931
35. Forrester, S. J., Kikuchi, D. S., Hernandes, M. S., Xu, Q., & Griendling, K. K. (2018). Reactive Oxygen Species in Metabolic and Inflammatory Signaling. Circulation Research, 122(6), 877–902. https://doi.org/10.1161/circresaha.117.311401
36. García-Sánchez, A., Miranda-Díaz, A. G., & Cardona-Muñoz, E. G. (2020). The Role of Oxidative Stress in Physiopathology and Pharmacological Treatment with Pro‐ and Antioxidant Properties in Chronic Diseases. Oxidative Medicine and Cellular Longevity, 2020(1), 2082145. https://doi.org/10.1155/2020/2082145
37. Tardif, J.-C. (2006). Antioxidants: The good, the bad and the ugly. Canadian Journal of Cardiology, 22, 61B-65B. https://doi.org/10.1016/s0828-282x(06)70988-6
38. Group, A.-T., Beta Carotene Cancer Prevention Study. (1994). The Effect of Vitamin E and Beta Carotene on the Incidence of Lung Cancer and Other Cancers in Male Smokers. The New England Journal of Medicine, 330(15), 1029–1035. https://doi.org/10.1056/nejm199404143301501
39. Yusri, K., Jose, S., Vermeulen, K. S., Tan, T. C. M., & Sorrentino, V. (2025). The role of NAD+ metabolism and its modulation of mitochondria in aging and disease. Npj Metabolic Health and Disease, 3(1), 26. https://doi.org/10.1038/s44324-025-00067-0
40. Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021). NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology, 22(2), 119–141. https://doi.org/10.1038/s41580-020-00313-x
41. Stein, L. R., & Imai, S. (2012). The dynamic regulation of NAD metabolism in mitochondria. Trends in Endocrinology & Metabolism, 23(9), 420–428. https://doi.org/10.1016/j.tem.2012.06.005
42. Cao, X., Wu, Y., Hong, H., & Tian, X. Y. (2022). Sirtuin 3 Dependent and Independent Effects of NAD+ to Suppress Vascular Inflammation and Improve Endothelial Function in Mice. Antioxidants, 11(4), 706. https://doi.org/10.3390/antiox11040706
43. Murata, M. M., Kong, X., Moncada, E., Chen, Y., Imamura, H., Wang, P., Berns, M. W., Yokomori, K., & Digman, M. A. (2019). NAD+ consumption by PARP1 in response to DNA damage triggers metabolic shift critical for damaged cell survival. Molecular Biology of the Cell, 30(20), 2584–2597. https://doi.org/10.1091/mbc.e18-10-0650
44. Massudi, H., Grant, R., Braidy, N., Guest, J., Farnsworth, B., & Guillemin, G. J. (2012). Age-Associated Changes In Oxidative Stress and NAD+ Metabolism In Human Tissue. PLoS ONE, 7(7), e42357. https://doi.org/10.1371/journal.pone.0042357
45. Ahmadi, A., Valencia, A. P., Begue, G., Norman, J. E., Fan, S., Durbin-Johnson, B. P., Jenner, B. N., Campbell, M. D., Reyes, G., Kapahi, P., Himmelfarb, J., Boer, I. H. de, Marcinek, D. J., Kestenbaum, B. R., Gamboa, J. L., & Roshanravan, B. (2025). A Pilot Trial of Nicotinamide Riboside and Coenzyme Q10 on Inflammation and Oxidative Stress in Chronic Kidney Disease. Clinical Journal of American Society of Nephrology, 267(13), 1844–1844. https://doi.org/10.2215/cjn.0000000624
46. Katayoshi, T., Uehata, S., Nakashima, N., Nakajo, T., Kitajima, N., Kageyama, M., & Tsuji-Naito, K. (2023). Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial. Scientific Reports, 13(1), 2786. https://doi.org/10.1038/s41598-023-29787-3
47. Dolopikou, C. F., Kourtzidis, I. A., Margaritelis, N. V., Vrabas, I. S., Koidou, I., Kyparos, A., Theodorou, A. A., Paschalis, V., & Nikolaidis, M. G. (2020). Acute nicotinamide riboside supplementation improves redox homeostasis and exercise performance in old individuals: a double-blind cross-over study. European Journal of Nutrition, 59(2), 505–515. https://doi.org/10.1007/s00394-019-01919-4
48. Sorrentino, S. A., Besler, C., Rohrer, L., Meyer, M., Heinrich, K., Bahlmann, F. H., Mueller, M., Horváth, T., Doerries, C., Heinemann, M., Flemmer, S., Markowski, A., Manes, C., Bahr, M. J., Haller, H., Eckardstein, A. von, Drexler, H., & Landmesser, U. (2010). Endothelial-Vasoprotective Effects of High-Density Lipoprotein Are Impaired in Patients With Type 2 Diabetes Mellitus but Are Improved After Extended-Release Niacin Therapy. Circulation, 121(1), 110–122. https://doi.org/10.1161/circulationaha.108.836346
49. El-Kady, R. R., Ali, A. K., Wakeel, L. M. E., Sabri, N. A., & Shawki, M. A. (2022). Nicotinamide supplementation in diabetic nonalcoholic fatty liver disease patients: randomized controlled trial. Therapeutic Advances in Chronic Disease, 13, 20406223221077958. https://doi.org/10.1177/20406223221077958
50. Poljsak, B. (2011). Strategies for Reducing or Preventing the Generation of Oxidative Stress. Oxidative Medicine and Cellular Longevity, 2011(1), 194586. https://doi.org/10.1155/2011/194586
51. Ji, L. L., Dickman, J. R., Kang, C., & Koenig, R. (2010). Exercise-Induced Hormesis may Help Healthy Aging. Dose-Response, 8(1), dose-response.09-048.Ji. https://doi.org/10.2203/dose-response.09-048.ji
52. Åsgård, R., Rytter, E., Basu, S., Abramsson-Zetterberg, L., Möller, L., & Vessby, B. (2007). High intake of fruit and vegetables is related to low oxidative stress and inflammation in a group of patients with type 2 diabetes. Scandinavian Journal of Food & Nutrition, 51(4), 149–158. https://doi.org/10.1080/17482970701737285